{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:34:20Z","timestamp":1773282860242,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/2319-4170.125650","type":"journal-article","created":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T16:19:12Z","timestamp":1412957952000},"page":"326","source":"Crossref","is-referenced-by-count":18,"title":["Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice"],"prefix":"10.1016","volume":"37","author":[{"given":"Wei-Chen","family":"Tai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Tsung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Chin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"King-Wah","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shue-Shian","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seng-Kee","family":"Chuah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Ming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Mou","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keng-Liang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"key-10.4103\/2319-4170.125650-1","first-page":"772","volume-title":"Current concepts in the management of Helicobacter infection.The Maastricht III Consensus Report","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"key-10.4103\/2319-4170.125650-2","first-page":"789","volume-title":"High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection","author":"Cammarota","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/2319-4170.125650-3","first-page":"1502","volume-title":"Helicobacter pylori and antibiotic resistance","author":"Megraud","year":"2007","journal-title":"Gut"},{"key":"key-10.4103\/2319-4170.125650-4","first-page":"523","volume-title":"Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts","author":"Parente","year":"2003","journal-title":"Dig Liver Dis"},{"key":"key-10.4103\/2319-4170.125650-5","first-page":"805","volume-title":"Helicobacter pylori eradication: Do we have another ace up our sleeve?","author":"Zullo","year":"2001","journal-title":"Dig Liver Dis"},{"key":"key-10.4103\/2319-4170.125650-6","doi-asserted-by":"crossref","unstructured":"Croom KF, Goh KL. Levofloxacin: A review of its use in the treatment of bacterial infections in the United States. Drugs 2003;63:2769-802.","DOI":"10.2165\/00003495-200363240-00008"},{"key":"key-10.4103\/2319-4170.125650-7","first-page":"421","volume-title":"Lansoprazole, levofloxacin and amoxicillin triple therapy vs.quadruple therapy as second-line treatment of resistant Helicobacter pylori infection","author":"Wong","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/2319-4170.125650-8","first-page":"488","volume-title":"Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: A meta-analysis","author":"Saad","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/2319-4170.125650-9","first-page":"3971","volume-title":"A new look at anti-Helicobacter pylori therapy","author":"Chuah","year":"2011","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/2319-4170.125650-10","first-page":"1039","volume-title":"Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori","author":"Tanaka","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/2319-4170.125650-11","first-page":"1017","volume-title":"Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: A randomized controlled trial","author":"Kuo","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/2319-4170.125650-12","first-page":"359","volume-title":"Levofloxacin-containing triple therapy to eradicate the persistent H.pylori after a failed conventional triple therapy","author":"Cheng","year":"2007","journal-title":"Helicobacter"},{"key":"key-10.4103\/2319-4170.125650-13","first-page":"177","volume-title":"Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori","author":"Hu","year":"2011","journal-title":"Am J Med Sci"},{"key":"key-10.4103\/2319-4170.125650-14","first-page":"216","volume-title":"Randomized comparison of two non-Bismuth-containing second-line rescue therapies for Helicobacter pylori","author":"Chuah","year":"2012","journal-title":"Helicobacter"},{"key":"key-10.4103\/2319-4170.125650-15","first-page":"572","volume-title":"Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatment for helicobacter pylori infection: A randomized comparative trial with crossover design","author":"Liou","year":"2010","journal-title":"Gut"},{"key":"key-10.4103\/2319-4170.125650-16","first-page":"195","volume-title":"Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia","author":"Hsu","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/2319-4170.125650-17","first-page":"159","volume-title":"Comparison of biopsy-based methods for the detection of Helicobacter pylori infection","author":"Yakoob","year":"2006","journal-title":"Br J Biomed Sci"},{"key":"key-10.4103\/2319-4170.125650-18","first-page":"1772","volume-title":"Clinical significance of oral urease in the diagnosis of H.pylori infection by 13C-urea breath test","author":"Peng","year":"2001","journal-title":"Dig Dis Sci"},{"key":"key-10.4103\/2319-4170.125650-19","first-page":"1808","volume-title":"American College of Gastroenterology guideline on the management of Helicobacter pylori infection","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/2319-4170.125650-20","first-page":"997","volume-title":"A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: A controlled trial","author":"Bilardi","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key-10.4103\/2319-4170.125650-21","first-page":"96","volume-title":"Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication","author":"Schrauwen","year":"2009","journal-title":"Neth J Med"},{"key":"key-10.4103\/2319-4170.125650-22","first-page":"652","volume-title":"Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple \"sequential\" or \"concomitant\" treatment to eradicate H.pylori infection","author":"Gisbert","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"key-10.4103\/2319-4170.125650-23","first-page":"420","volume-title":"Randomized days of esomeprazole, moxifloxacin, and amoxicillin for trial on 14 versus 7 second-line or rescue treatment of Helicobacter pylori infection","author":"Miehlke","year":"2011","journal-title":"Helicobacter"},{"key":"key-10.4103\/2319-4170.125650-24","first-page":"371","volume-title":"Adverse reactions to fluoroquinolones.An overview on mechanistic aspects","author":"De","year":"2001","journal-title":"Curr Med Chem"},{"key":"key-10.4103\/2319-4170.125650-25","first-page":"237","volume-title":"Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole","author":"Marzio","year":"2006","journal-title":"Helicobacter"},{"key":"key-10.4103\/2319-4170.125650-26","first-page":"409","volume-title":"Worldwide H.pylori antibiotic resistance: A systematic review","author":"De","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"key-10.4103\/2319-4170.125650-27","first-page":"283","volume-title":"Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism","author":"Sheu","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/2319-4170.125650-28","first-page":"48","volume-title":"Bioinformatics research on inter-racial difference in drug metabolism.Analysis on frequencies of mutant alleles and poor metabolizers on CYP2D6 and CYP2C19","author":"Shimizu","year":"2003","journal-title":"Drug Metab Pharmacokinet"},{"key":"key-10.4103\/2319-4170.125650-29","first-page":"230","volume-title":"Racial differences in birth weight of term infants in a northern California population","author":"Madan","year":"2002","journal-title":"J Perinatol"},{"key":"key-10.4103\/2319-4170.125650-30","first-page":"275","volume-title":"A report card to grade Helicobacter pylori therapy","author":"Graham","year":"2007","journal-title":"Helicobacter"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T17:28:05Z","timestamp":1538155685000},"score":1,"resource":{"primary":{"URL":"http:\/\/biomedj.cgu.edu.tw\/pdfs\/2014\/37\/5\/images\/BiomedJ_2014_37_5_326_125650.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"alternative-id":["125650"],"URL":"https:\/\/doi.org\/10.4103\/2319-4170.125650","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}